SCHEMBL92834

SCHEMBL92834

CCC(=O)NS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5379762 0.97 MEN1 (0.39)
SCHEMBL3713808 0.83
SCHEMBL6059202 0.80 MEN1 (0.42)
SCHEMBL6015 0.79 HDAC3 (0.50)
SCHEMBL25838055 0.79
SCHEMBL4766625 0.78 MEN1 (0.40)
SCHEMBL177491 0.78
SCHEMBL14178232 0.78 CA2 (0.38)
SCHEMBL18778812 0.78 LDHA (0.42)
SCHEMBL18937193 0.77 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720034-A1 NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS Zydus Lifesciences Limited (IN) 2026-04-08 EP claimed
EP-4686469-A1 CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF DIABETES-ASSOCIATED COMORBIDITIES Dompé farmaceutici SpA (IT) 2026-02-04 EP claimed
EP-4563594-A1 CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF TUMORS WITH LOW STROMAL CAV1 LEVELS Dompe' Farmaceutici SpA (IT) 2025-06-04 EP claimed
EP-4548916-A1 IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME SARCOMAS Dompé farmaceutici SpA (IT) 2025-05-07 EP claimed
US-12268671-B2 IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy DOMPÉ FARMACEUTICI S.P.A. (IT) 2025-04-08 US claimed
EP-3700514-B1 COMBINATION OF IL-8 INHIBITORS AND IL-6/GP-130 INHIBITORS FOR USE IN THE TREATMENT OF LUNG METASTASIS ASSOCIATED TO OSTEOSARCOMA DOMPE FARM SPA (IT) 2025-03-19 EP claimed
US-20250009719-A1 IL-8 INHIBITORS FOR USE IN THE TREATMENT AND/OR PREVENTION OF BACTERIAL SECONDARY INFECTIONS DOMPÉ FARMACEUTICI S.P.A. (IT) 2025-01-09 US claimed
WO-2024252254-A1 NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS ZYDUS LIFESCIENCES LIMITED (IN) 2024-12-12 WO claimed
US-12133843-B2 IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections DOMPÉ FARMACEUTICI S.P.A. (IT) 2024-11-05 US claimed
US-20240156757-A1 CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES DOMPE' FARMACEUTICI SPA (IT) 2024-05-16 US claimed
EP-1049376-B1 SELECTIVE HERBICIDES BASED ON N-ARYL- TRIAZOLINE(THI)ONS AND N-ARLYSULFONYLAMINO (THIO)CARBONYL- TRIAZOLINE(THI) ONS BAYER AG (DE) 2002-10-16 EP claimed
EP-1221848-A1 SELECTIVE HERBICIDES ON THE BASIS OF N-ARYL-TRIAZOLINE(THI)ONES Bayer Aktiengesellschaft (DE) 2002-07-17 EP claimed
US-6297192-B1 MIXTURES OF HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-10-02 US claimed
WO-2001039597-A2 N-ARYL-URACILE-BASED HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-06-07 WO claimed
EP-0813519-B1 SULFONYLALKANOYLAMINO HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS SEARLE & CO (US) 2001-05-09 EP claimed
WO-2001022819-A1 SELECTIVE HERBICIDES ON THE BASIS OF N-ARYL-TRIAZOLINE(THI)ONES BAYER AKTIENGESELLSCHAFT (DE) 2001-04-05 WO claimed
EP-1049376-A1 SELECTIVE HERBICIDES BASED ON N-ARYL- TRIAZOLINE(THI)ONS AND N-ARLYSULFONYLAMINO (THIO)CARBONYL- TRIAZOLINE(THI) ONS Bayer Aktiengesellschaft (DE) 2000-11-08 EP claimed
WO-1999052906-A1 SUBSTITUTED OXAZOLYLE AND THIAZOLYL URACIL HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-10-21 WO claimed
WO-1999037153-A1 SELECTIVE HERBICIDES BASED ON N-ARYL- TRIAZOLINE(THI)ONS AND N-ARLYSULFONYLAMINO (THIO)CARBONYL- TRIAZOLINE(THI) ONS BAYER AKTIENGESELLSCHAFT (DE) 1999-07-29 WO claimed
EP-0813519-A1 SULFONYLALKANOYLAMINO HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1997-12-29 EP claimed